MedWatch

EU drugs agency can clear Omicron shot in 4 months if needed

The European Medicines Agency would use expedited procedures to approve new versions of the Covid-19 vaccines to address the omicron variant should the current ones prove insufficient to fight it off.

Photo: Peter Dejong/AP/Ritzau Scanpix

The European Medicines Agency would use expedited procedures to approve new versions of the Covid-19 vaccines to address the omicron variant should the current ones prove insufficient to fight it off.

Emer Cooke, the agency’s director, told the European Parliament on Tuesday that regulatory approval could be completed in three to four months from when the companies are ready to move forward, but that testing is ongoing to evaluate how the variant responds to the current vaccines.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Latest news

See all jobs